Auxilium Pharmaceuticals, Inc. and Pfizer Enter Agreement to Develop and Commercialize XIAFLEX(TM) in Europe
December 17, 2008


Transcept Announces FDA Acceptance for Review of New Drug Application for Intermezzo®
December 16, 2008


Epocrates Offers International Market Research Panel
November 20, 2008


Affymax Announces Another Favorable Data Monitoring Committee Review of Phase 3 Hematide Program
November 20, 2008


Epocrates Survey Identifies Trends in Online Resource Use Among Physicians
November 18, 2008


Affymax Completes Enrollment in Phase 3 Program for Hematide in Chronic Renal Failure with Completion of Enrollment in EMERALD 2, the Final of Four Phase 3 Clinical Trials of Hematide™
November 17, 2008


ISTA Pharmaceuticals Ranked Number Twelve in Deloitte's Technology Fast 500 Program for Fastest Growing Companies in North America
November 13, 2008


ISTA Pharmaceuticals Files New Drug Application with U.S. FDA for Bepreve™
November 13, 2008


Fifty Thousand Physicians Choose Epocrates iPhone App
November 6, 2008


Affymax Announces New Data Presented on the Long-Term Safety and Effectiveness of Hematide(TM) to Treat Anemia in Chronic Renal Failure Patients with Monthly Dosing
November 6, 2008


Affymax Completes Enrollment in PEARL 2, the Second of Four Phase 3 Clinical Trials of Hematide to Treat Anemia in Chronic Renal Failure Patients
November 3, 2008


Transcept Submits NDA for Intermezzo® for Treatment of Middle-of-the-Night Awakenings
October 1, 2008


ISTA Pharmaceuticals Receives $65 Million Funding Commitment
September 26, 2008


Concert Pharmaceuticals Presents Preclinical Results Supporting Co-Administration of CTP-347 and Tamoxifen
September 25, 2008


One Million Epocrates MobileCME Courses Completed
September 25, 2008


Oriel Therapeutics Appoints Richard Fuller as Chief Executive Officer
September 23, 2008


Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX(TM) Phase IIb Study for Peyronie's Disease
September 17, 2008


Apple iPhone Becomes a Patient Safety Device with Epocrates
September 15, 2008


Intarcia Therapeutics, Inc. Announces Appointment of Kenneth Luskey, M.D. as Vice President, Clinical Research
September 9, 2008


Novacea, Inc. and Transcept Pharmaceuticals, Inc. Sign Merger Agreement
September 2, 2008


Patent Issued Related to Prometheus Proprietary Test; CBir1 Antigen Test Included in Diagnostic for Inflammatory Bowel Disease
August 21, 2008


Affymax Announces Favorable Data Monitoring Committee Review of Phase 3 Hematide Program
August 7, 2008


WorldHeart Closes US$30 Million in Financing
August 1, 2008


Angiotech To Establish Separate Operating And Royalty Businesses
July 7, 2008


Pearl Therapeutics Closes $18 Million Financing
July 2, 2008


Tioga Pharmaceuticals’ Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome
May 20, 2008


Aureon Laboratories Introduces Prostate Px® , First Biopsy-Based Test to Predict Prostate Cancer Disease Progression and Recurrence
May 19, 2008


Affymax and Takeda Announce Long-Term Hematide Safety and Effectiveness Data from Phase 2 Clinical Trials in Chronic Kidney Disease Patients with Anemia
May 12, 2008


NxStage Announces Supply Agreement With Kawasumi Laboratories for Blood Tubing Sets
May 7, 2008


ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing
April 30, 2008


CoNCERT Pharmaceuticals Raises $37 Million in Series C Financing
April 30, 2008


Stromedix Raises $25 Million Series B for Fibrosis Programs, Begins Clinical Trial
April 21, 2008


IlluminOss Medical Completes $11 Million Series B Financing
April 18, 2008


Metabasis Therapeutics Raises Approximately $10 Million Through a Warrant Exchange and Concurrent Private Placement
April 16, 2008


Apple Announces iPhone 2.0 Software Beta
March 6, 2008


Artisan Pharma's Lead Product, ART-123, Approved in Japan
February 22, 2008


ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom™ Combination Therapy with Lucentis®
February 22, 2008


SGX Initiates Phase I Trials for SGX523
January 16, 2008


Epocrates Inc. Announces Strategic Investment by Goldman Sachs
January 7, 2008


NxStage Medical Announces Needle Supply Agreement with DaVita
January 7, 2008


Aspreva's Plan of Arrangement with Galenica Completed
January 3, 2008


ISTA Pharmaceuticals Submits New Drug Application for Xibrom(TM) QD (once-daily)
December 20, 2007


Kalypsys Initiates Phase IIa Clinical Trial of Topical iNOS Inhibitor
December 18, 2007


Auxilium Pharmaceuticals, Inc. Completes Enrollment in Two Phase III Clinical Trials of XIAFLEX(TM) for Dupuytren's Contracture
December 17, 2007


SGX Pharmaceuticals Submits Investigational New Drug Application for SGX523, a Highly Potent, Selective, Orally Bioavailable cMET Inhibitor
December 3, 2007


Prometheus Licenses Colal-Pred® From Alizyme
November 29, 2007


NxStage Medical Establishes $50 Million Credit Facility with a Group of Lenders Led by Merrill Lynch Capital
November 21, 2007


SGX Pharmaceuticals Announces $25 Million Private Placement
November 20, 2007


Prescription for Success: Epocrates for BlackBerry -
Popular Medical Software Now Available for BlackBerry Smartphones
November 14, 2007


BioRelix and Dalton Medicinal Chemistry Sign Research Agreement to Capitalize on RiboSwitch Technology
November 13, 2007


ISTA Pharmaceuticals Presents Results from Two Phase III Clinical Trials of Xibrom(TM) QD (Once-daily) Formulation at the American Academy of Ophthalmology Annual Meeting
November 12, 2007


Prometheus Laboratories Inc. to Acquire GlaxoSmithKline (GSK) Bowel Drug
November 7, 2007


Affymax® Announces Hematide™ Successfully Restores Hemoglobin in Patients with Pure Red Cell Aplasia (PRCA)
November 5, 2007


Relypsa formed with $33 Million Series A Funding to discover and develop polymeric drugs.
October 29, 2007


GlaxoSmithKline (GSK) and Tolerx, Inc. Form Collaboration Worth Up to $700 Million
October 23, 2007


Gary Shearman, Ph.D. Joins Board of Artisan Pharma, Inc.
October 23, 2007


Aspreva to be Acquired by Galenica For US$915 Million
October 17, 2007


Aureon Laboratories to Collaborate with UCSF on Research Study to Construct Predictive Models for GM-CSF Treatment Response in Patients with Prostate Cancer
October 15, 2007


Affymax Doses First Patient in the Phase 3 Clinical Program of Hematide™ to Treat Anemia in Chronic Renal Failure Patients
October 11, 2007


NxStage Medical Completes Acquisition of Medisystems
October 1, 2007


Spiration, Inc. Announces First Patient Enrollment in U.S. Pivotal Trial of Minimally Invasive Treatment for Severe Emphysema
September 26, 2007


ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments
September 26, 2007


Pearl Therapeutics Raises $15.5 Million in Private Financing
September 6, 2007


ISTA Pharmaceuticals Completes $36.75 Million Private Financing
June 29, 2007


TransOral Pharmaceuticals, Inc. Changes Name to Transcept Pharmaceuticals, Inc.
June 22, 2007


BioRelix Announces $25.75 Million Series A
June 11, 2007


Auxilium Pharmaceuticals Announces Sale of Common Stock
June 8, 2007


Amgen to Acquire Ilypsa, a Private San Francisco Bay Area Biotechnology Company Focused on Kidney Disease Care
June 4, 2007


NxStage® Medical Announces Agreement to Acquire Medisystems Corporation and Certain Affiliated Entities
June 4, 2007


TIBCO to Acquire Spotfire
May 1, 2007


Intarcia Raises $50 Million in a Series BB Financing
March 19, 2007


New Leaf Venture Partners and TPG Growth Co-Lead $20 Million Series B Financing in ProteoGenix
March 14, 2007


TransOral Pharmaceuticals Raises $40 Million in Series D Financing
March 6, 2007


Adeza to Be Acquired by Cytyc for $24 Per Share
February 12, 2007


Cerexa to be Acquired by Forest Laboratories for $480 Million Plus Potential $100 Million Milestone Payment
December 14, 2006


Concert Pharmaceuticals Raises $48.5 Million in Series B Financing
November 30, 2006


Merck & Co., Inc. to Acquire Sirna Therapeutics, Inc.
October 30, 2006


VaxInnate Secures $40 Million Series C Financing
October 25, 2006


Barrier Therapeutics, Inc. to Raise $25 Million in Registered Direct Offering
September 15, 2006


Artisan Pharma, Inc. Raises $39 Million in a Series A Financing
September 2, 2006


New Leaf Venture Partners Announces $12 Million Financing in Tioga Pharmaceuticals
January 9, 2006


New Leaf Venture Partners Announces $8.5 Million Financing in TransOral Pharmaceuticals
October 28, 2005


New Leaf Venture Partners Announces $3.5 Million Financing in Direct Flow Medical
September 7, 2005


New Leaf Venture Partners Announces $8 Million Investment in Cerexa's $50 Million Financing; Investment is First from NLV Partners' Recently Announced Fund Dedicated to Healthcare Technologies
August 23, 2005